Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Frontiers in Cell and Developmental Biology|March 21, 2017
DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for ImmunotherapyElfriede NoessnerCancer Immunology, Immunotherapy : CII|September 10, 2005
Effects of thermal stress on tumor antigenicity and recognition by immune effector cellsValeria Milani, Elfriede NoessnerCancers|December 10, 2021
Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological ApproachMariangela Mancini, Marialaura Righetto, Elfriede NoessnerSeminars in Cancer Biology|July 28, 2007
Immune suppression in renal cell carcinomaBernhard Frankenberger, Elfriede Noessner, Dolores J SchendelNephron. Experimental Nephrology|December 3, 2011
Dendritic cells in experimental renal inflammation--Part IMaja Lindenmeyer, Elfriede Noessner, Peter J Nelson, et al.Nephron. Experimental Nephrology|December 3, 2011
Dendritic cells in human renal inflammation--Part IIElfriede Noessner, Maja Lindenmeyer, Peter J Nelson, et al.Targeted Oncology|June 5, 2020
Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell CancerJörg Hänze, Moritz Wegner, Elfriede Noessner, et al.Cancer Research|January 26, 2002
Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cellsChristine S Falk, Elfriede Noessner, Elisabeth H Weiss, et al.European Journal of Cell Biology|April 5, 2011
Hsp70, a messenger from hyperthermia for the immune systemAnna Jolesch, Katharina Elmer, Henriette Bendz, et al.Journal of Translational Medicine|July 28, 2005
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinomaChristiane Geiger, Sybille Regn, Andreas Weinzierl, et al.Pageof 8